Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73

Oncogene (2010) 29, 2024–2035; doi:10.1038/onc.2009.490; published online 8 February 2010
Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73

J van Dieck1, T Brandt1, D P Teufel1, D B Veprintsev1, A C Joerger1 and A R Fersht1

1MRC Centre for Protein Engineering, Hills Road, Cambridge, UK

Correspondence: Professor AR Fersht, MRC Centre for Protein Engineering, Cambridge University, Hills Road, Cambridge, Cambs CB2 0QH, UK. E-mail: arf25@cam.ac.uk

Received 6 August 2009; Revised 16 October 2009; Accepted 27 October 2009; Published online 8 February 2010.
Top of page
Abstract

S100 proteins modulate p53 activity by interacting with its tetramerization (p53TET, residues 325–355) and transactivation (residues 1–57) domains. In this study, we characterized biophysically the binding of S100A1, S100A2, S100A4, S100A6 and S100B to homologous domains of p63 and p73 in vitro by fluorescence anisotropy, analytical ultracentrifugation and analytical gel filtration. We found that S100A1, S100A2, S100A4, S100A6 and S100B proteins bound different p63 and p73 tetramerization domain variants and naturally occurring isoforms with varying affinities in a calcium-dependent manner. Additional interactions were observed with peptides derived from the p63 and p73 N-terminal transactivation domains. Importantly, S100 proteins bound p63 and p73 with different affinities in their different oligomeric states, similarly to the differential modes of binding to p53. On the basis of our data, we hypothesize that S100 proteins regulate the oligomerization state of all three p53 family members and their isoforms, with a potential physiological relevance in developmental and disease-related processes. The regulation of the p53 family by S100 is complicated and depends on the target preference of each individual S100 protein, the concentration of the proteins and calcium, as well as the splicing variation of p63 or p73. Our results outlining the complexity of the interaction should be considered when studying the functional effects of S100 proteins in their biological context.
Keywords:

S100; p63; p73; tumor suppressor; protein–protein interaction